Obeticholic Acid Ameliorates Non-Alcoholic Fatty Liver Disease by Improving Metabolic Profile in Dietary Obesity, but Not in Obese, Diabetic FOZ/FOZ Mice von Haczeyni, F, Poekes, L, Barn, V, Mridha, A.R, Haigh, W.G, Ioannou, G.N, Yeh, M.M, Leclercq, I.A, Teoh, N.C, Farrell, G.C

Volltext

Are Patients with Child's A Cirrhosis and Hepatocellular Carcinoma Appropriate Candidates for Liver Transplantation? von Berry, K., Ioannou, G. N.

Volltext

Age differences in the association of comorbid burden with adverse outcomes in SARS-CoV-2 von O'Hare, A. M., Berry, K., Fan, V. S., Crothers, K., Eastment, M. C., Dominitz, J. A., Shah, J. A., Green, P., Locke, E., Ioannou, G. N.

Volltext

SAT-311 - Obeticholic Acid Ameliorates Non-Alcoholic Fatty Liver Disease by Improving Metabolic Profile in Dietary Obesity, but Not in Obese, Diabetic FOZ/FOZ Mice von Haczeyni, F., Poekes, L., Barn, V., Mridha, A.R., Haigh, W.G., Ioannou, G.N., Yeh, M.M., Leclercq, I.A., Teoh, N.C., Farrell, G.C.

Volltext